Detection of Chromosomal Aberrations in Urine Samples Using Fluorescent in Situ Hybridization (FISH) (UroVysion Test)

Completed

Conditions studied: Bladder Cancers

In brief

The purpose of the study is the identification of chromosomal aberrations in urine samples. The imaging system is intended for diagnostic use as an aid to the pathologist in the detection, counting and classification of UroVysion FISH stained Urine samples.

Key facts

Study ID

NCT01264744

Run by

Applied Spectral Imaging Ltd.

People needed

174

Starts

2009-11-01

Expected to finish

2010-08-01

Last updated by the study team

2010-12-23

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Well stained slides with bright FISH signals

You may not qualify if…

• Very old slides that were already bleached

Where it is running

• VA Hospital — Los Angeles, California, United States
• PLUS Diagnostics — Union, New Jersey, United States
• Sheila Dobin, Ph.D. — Temple, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.